Treatment for Recurrent Oral Herpes Simplex Virus (HSV)
First-Line Treatment Options
- The American Academy of Dermatology recommends oral antiviral therapy with valacyclovir 500 mg twice daily for 5 days, which should be initiated at the first sign or symptom of an outbreak to effectively reduce duration and severity of symptoms 1, 2
- Oral antiviral therapy is more effective than topical treatments and should be initiated as early as possible, ideally during the prodromal phase or within 1 day of lesion onset 1
Suppressive Therapy for Frequent Recurrences
- For patients with frequent recurrences (≥6 episodes per year), daily suppressive therapy is recommended 3, 4
- Suppressive therapy can reduce recurrence frequency by ≥75% in patients with frequent episodes 3, 4
Important Clinical Considerations
- Treatment is most effective when initiated during the prodromal phase (tingling, burning, itching) or within 1 day of lesion appearance 1, 2
- Delayed treatment (beyond 72 hours after symptom onset) significantly reduces effectiveness 3
- Patients should be counseled that antiviral medications control symptoms but do not eradicate the virus or prevent all recurrences 5, 4
Special Populations
- Resistance to acyclovir and related drugs is rare in immunocompetent patients but more common in immunocompromised individuals 4
- In HIV-infected patients, recurrent orolabial herpes may require treatment with acyclovir 400 mg 3-5 times daily until clinical resolution 3